AXYS PHARMECUETICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: AXYS PHARMECUETICALS INC, 10-Q, EX-10.132, 2000-11-14
Next: TV GUIDE INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS, STATEMENTS OF OPERATIONS AND STATEMENTS OF CASH
FLOWS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30,
2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
AND NOTES THERETO.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          40,008
<SECURITIES>                                    11,307
<RECEIVABLES>                                    1,163
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                58,308
<PP&E>                                          43,352
<DEPRECIATION>                                (29,860)
<TOTAL-ASSETS>                                 120,823
<CURRENT-LIABILITIES>                           16,188
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       343,171
<OTHER-SE>                                      74,217
<TOTAL-LIABILITY-AND-EQUITY>                   120,823
<SALES>                                          1,209
<TOTAL-REVENUES>                                 6,705
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                37,969
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,061
<INCOME-PRETAX>                               (29,656)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (29,656)
<DISCONTINUED>                                  35,841
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,185
<EPS-BASIC>                                     0.18
<EPS-DILUTED>                                     0.18


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission